...
首页> 外文期刊>European review for medical and pharmacological sciences. >miRNA-370 acts as a tumor suppressor via the downregulation of PIM1 in hepatocellular carcinoma
【24h】

miRNA-370 acts as a tumor suppressor via the downregulation of PIM1 in hepatocellular carcinoma

机译:miRNA-370通过下调PIM1在肝细胞癌中起到抑癌作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: Hepatocellular carcinoma (HCC) is a primary malignancy of liver. Nowadays HCC is one of the most common and aggressive malignancies worldwide. This study shows the aberrant up-regulation or down-regulation of miR-370correlates with the development and prognosis of different human malignancies including HCC. MATERIALS AND METHODS: The HCC cell lines were used as model cell lines and the anti-tumor effect of miR-370 in vitro were examined. The level of miR-370 in HCC cells was determined by qRT-PCR and restored in GC cells by using miR-370 mimic. Moreover, the target gene of miR-370 was then identified. RESULTS: The expression of miR-370 in HCC cell lines was significantly lower than that in the other human liver cells. The miR-370 acted as a tumor suppressor in HCC. Moreover, it showed that miR-370 exerted anti-tumor effect by targeting PIM1 directly, a serine/threonine-specific kinase involved in the development and progression of HCC. CONCLUSIONS: miR-370 acted as the tumor suppressor in HCC and was a potential therapeutic target for HCC treatment.
机译:目的:肝细胞癌(HCC)是原发性肝癌。如今,肝癌是全球最常见,最具侵略性的恶性肿瘤之一。这项研究表明,miR-370异常上调或下调与包括HCC在内的各种人类恶性肿瘤的发生和预后相关。材料与方法:以肝癌细胞为模型细胞,观察miR-370的体外抗肿瘤作用。通过qRT-PCR确定HCC细胞中miR-370的水平,并使用miR-370模拟物在GC细胞中恢复。此外,然后鉴定了miR-370的靶基因。结果:miR-370在肝细胞癌中的表达明显低于其他人类肝细胞。 miR-370在HCC中起着抑癌作用。此外,它表明miR-370通过直接靶向PIM1发挥抗肿瘤作用,PIM1是一种参与肝癌发生和发展的丝氨酸/苏氨酸特异性激酶。结论:miR-370在HCC中起着抑癌作用,是HCC治疗的潜在治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号